文献速递基础与转化研究新药、器械与细胞基因治疗研发

将致病性T细胞转化为功能稳定的Treg细胞以实现寻常型天疱疮的抗原特异性免疫抑制

Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris.
PubMed 文献 · Sci Transl Med · 2025-10-22

研究开发了一种策略,将Dsg3特异性致病性自身反应性CD4+ T细胞在体外转化为功能稳定的Foxp3+调节性T细胞(S/F-iTreg)。在寻常型天疱疮动物模型中,这些细胞特异性扩增并选择性抑制Dsg3特异性Tfh细胞和B细胞增殖及抗Dsg3自身抗体形成,从而缓解疾病进展而不引起全身性免疫抑制。患者外周血T细胞也可高效生成具有类似功能的人S/F-iTreg细胞。

要点

  • Dsg3特异性致病性CD4+ T细胞可在体外转化为功能稳定的Foxp3+ S/F-iTreg细胞。
  • 在动物模型中,S/F-iTreg细胞特异性扩增并选择性抑制Dsg3特异性Tfh和B细胞增殖及自身抗体形成。
  • 患者外周血T细胞可高效生成具有类似功能的人S/F-iTreg细胞。

核心结论

  • 致病性自身反应性T细胞可转化为保留抗原特异性的疾病特异性Treg细胞,从而实现自身免疫病的抗原特异性和疾病特异性治疗。

研究设计与样本

  • 研究通过药物诱导Foxp3和共刺激依赖的表观遗传修饰,在体外将Dsg3特异性致病性自身反应性CD4+ T细胞转化为S/F-iTreg细胞。
  • 在寻常型天疱疮动物模型中评估S/F-iTreg细胞的功能,并从患者外周血T细胞生成人S/F-iTreg细胞。

主要发现

  • 在寻常型天疱疮动物模型中,Dsg3特异性S/F-iTreg细胞通过识别内源性Dsg3在皮肤引流淋巴结中特异性扩增。
  • S/F-iTreg细胞选择性抑制Dsg3特异性Tfh细胞和B细胞增殖及抗Dsg3自身抗体形成,不影响总B细胞群,从而缓解疾病进展而不诱导全身性免疫抑制。
  • 具有类似功能的人S/F-iTreg细胞可从寻常型天疱疮患者外周血T细胞高效生成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antigen-specific immunotherapy represents one candidate strategy for treating autoimmune diseases such as pemphigus vulgaris, a skin autoimmune disorder mediated by anti-desmoglein 3 (Dsg3) autoantibodies. We developed a therapeutic strategy by which Dsg3-specific pathogenic autoreactive CD4+ T cells were converted in vitro into functionally stable Foxp3+ regulatory T (Treg) cells, designated stable and functional induced Treg (S/F-iTreg) cells. The conversion was achieved by pharmacological induction of Foxp3 and costimulation-dependent installation of Treg cell-specific epigenetic changes. In an animal model of pemphigus vulgaris, the Dsg3-specific S/F-iTreg cells expanded specifically in the skin-draining lymph nodes through recognition of endogenous Dsg3. They selectively inhibited Dsg3-specific T follicular helper cell and B cell proliferation and, consequently, anti-Dsg3 autoantibody formation, without affecting the total B cell population, thereby mitigating disease progression without inducing systemic immunosuppression. Human S/F-iTreg cells with similar functions could also be efficiently generated from peripheral blood T cells of patients with pemphigus vulgaris. This study demonstrates that pathogenic autoreactive T cells can be converted into disease-specific Treg cells retaining antigen specificity, enabling antigen- and disease-specific treatment of autoimmune disease.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Mukai M, Takahashi H, Kubo Y, et al. Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris. Sci Transl Med. 2025. PMID: 41124284. doi:10.1126/scitranslmed.adq9913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。